Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism

Journal of Virology

Volumn 71, Issue 9, 1997, Pages 6582-6592

  Spearman, Paul ^a   Horton, Robert ^b   Ratner, Lee ^b   Kuli Zade, Irina ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX PROTEIN; MUTANT PROTEIN;

ANIMAL CELL; ARTICLE; CONFORMATIONAL TRANSITION; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMBRANE BINDING; MYRISTYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; BINDING SITES; CELL LINE; CELL MEMBRANE; CENTRIFUGATION; CERCOPITHECUS AETHIOPS; CYTOSOL; ENDOPEPTIDASES; GENE PRODUCTS, GAG; HIV ANTIGENS; HIV-1; HUMANS; MEMBRANE FUSION; MYRISTIC ACID; MYRISTIC ACIDS; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN PRECURSORS; SEQUENCE DELETION; T-LYMPHOCYTES; VIRAL PROTEINS;

EID: 0030763024     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Aderem, A. 1992. The MARCKS brothers: a family of protein kinasc C substrates. Cell 71:713-716.
2. Aderem, A. 1992. The role of myristoylated protein kinase C substrates in intracellular signaling pathways in macrophages. Curr. Top. Microhiol. Immunol. 181:189-207.
3. Ames, J. B., T. Tanaka, L. Stryer, and M. Ikura. 1994. Secondary structure of myristoylated recoverin determined by three-dimensional heteronuclear NMR: implications for the calcium-myristoyl switch. Biochemistry 33:10743-10753.
4. Boman, A. L., and R. A. Kahn. 1995. Arf proteins: the membrane traffic police? Trends Biochem. Sci. 20:147-151.
5. Bryant, M., and L. Ratner. 1990. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Null. Acad. Sci. USA 87:523-527.
6. Bukrinskaya, A. G., A. Ghorpade, N. K. Heinzinger, T. E. Smithgall, R. E. Lewis, and M. Stevenson. 1996. Phosphorylution-dcpcndeni human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. Proc. Natl. Acad. Sci. USA 93:367-371.
7. Bukrinsky, M. I., S. Haggerty, M. P. Dempsey, N. Sharova, A. Adzhubel, L. Spitz, P. Lewis, D. Goldfarb, M. Emerman, and M. Stevenson. 1993. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365:666-669.
8. Burnette, B., G. Yu, and R. L. Felsted. 1993. Phosphorylation of HIV-1 gag proteins by protein kinase C. J. Biol. Chem. 268:8698-8703.
9. Carrillo, A., and L. Ratner. 1996. Human immunodeficiency virus type 1 tropism for T-lymphoid cell lines: role of the V3 loop and C4 envelope determinants. J. Virol. 70:1301-1309.
10. Chong, L. D., and J. K. Rose. 1994. Interactions of normal and mutant vesicular stomatitis virus matrix proteins with the plasma membrane and nucleocapsids. J. Virol. 68:441-447.
11. Chong, L. D., and J. K. Rose. 1993. Membrane association of functional vesicular stomatitis virus matrix protein in vivo. J. Virol. 67:407-414.
12. Dorfman, T., F. Mammano, W. A. Haseltine, and H. G. Gottlinger. 1994. Role of the matrix protein in the virion association of the human immuno-deficiency virus type 1 envelope glycoprotein. J. Virol. 68:1689-1696.
13. Franke, E. K., H. E. Yuan, K. L. Bossolt, S. P. Goff, and J. Luban. 1994. Specificity and sequence requirements for interactions between various retroviral Gag proteins. J. Virol. 68:5300-5305.
14. Freed, E. O., G. Englund, and M. A. Martin. 1995. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J. Virol. 69:3949-3954.
15. Freed, E. O., and M. A. Martin. 1995. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69:1984-1989.
16. Gallay, P., V. Stitt, C. Mundy, M. Oettinger, and D. Trono. 1996. Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J. Virol. 70:1027-1032.
17. Gallay, P., S. Swingler, C. Aiken, and D. Trono. 1995. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 80:379-388.
18. Gallay, P., S. Swingler, J. Song, F. Bushman, and D. Trono. 1995. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 83:569-576.
19. Gottlinger, H. G., J. G. Sodroski, and W. A. Haseltine. 1989. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:5781-5785.
20. Hill, C. P., D. Worthylake, D. P. Bancroft, A. M. Christensen, and W. I. Sundquist. 1996. Crystal struciures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc. Natl. Acad. Sci. USA 93:3099-3104.
21. Karacostas, V., K. Nagashima, M. A. Gonda, and B. Moss. 1989. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector. Proc. Natl. Acad. Sci. USA 86:8964-8967.
22. Mergener, K., M. Facke, R. Welker, V. Brinkmann, H. R. Gelderblom, and H. G. Krausslich. 1992. Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells. Virology 186:25-39.
23. Morikawa, Y., T. Kishi, W. H. Zhang, M. V. Nermut, D. J. Hockley, and I. M. Jones. 1995. A molecular determinant of human immunodeficiency virus particle assembly located in matrix antigen p17. J. Virol. 69:4519-4523.
24. Moss, B., O. Elroy-Stein, T. Mizukami, W. A. Alexander, and T. R. Fuerst. 1990. Product review. New mammalian expression vectors. Nature 348:91-92.
25. Nermut, M. V., C. Grief, S. Hashmi, and D. J. Hockley. 1993. Further evidence of icosuhedral symmetry in human and simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 9:929-938.
26. Nermut, M. V., D. J. Hockley, J. B. Jowett, I. M. Jones, M. Garreau, and D. Thomas. 1994. Fullerene-like organization of HIV gag-protein shell in virus-like particles produced hy recombinant buculovirus. Virology 198:288-290.
27. Platt, E. J., and O. K. Haffur. 1994. Characterization of human immunodeficiency virus type 1 Pr55gag membrane association in a cell-free system: requirement for a C-terminal domain. Proc. Null. Acad. Sci. USA 91:4594-4598.
28. Rao, Z., A. S. Belyaev, E. Fry, P. Roy, I. M. Jones, and D. I. Stuart. 1995. Crystal structure of SIV matrix antigen and implications for virus assembly. Nature 378:743-747.
29. Ratner, L., A. Fisher, L. L. Jagodzinski, H. Mitsuya, R. S. Liou, R. C. Gallo, and F. Wong-Staal. 1987. Complete nucleotidc sequences of functional clones of the AIDS virus. AIDS Res. Hum, Retroviruses 3:57-69.
30. Rose, J. K., L. Buonocore, and M. A. Whitt. 1991. A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. BioTechniques 10:520-525.
31. Rover, M., S. S. Hong, B. Gay, M. Cerutti, and P. Boulanger. 1992. Expression and extracellular release of human immunodeficiency virus type 1 Gag precursors by recombinant baculovirus-infected cells. J. Virol. 66:3230-3235.
32. gag: identification of epitopes exposed at the surfaces of infected cells. J. Virol. 65:4798-4804.
33. Spearman. P. Unpublished observations.
34. Spearman, P., J. J. Wang, N. Vander Heyden, and L. Ratner. 1994. Identi- fication of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J. Virol. 68:3232-3242.
35. Tanaka, T., J. B. Ames, T. S. Harvey, L. Stryer, and M. Ikura. 1095, Sequestration of the membrane-targeting myristoyl group of recoverin in the calcium-free state. Nature 376:444-447.
36. von Schwedler, U., R. S. Kornbluth, and D. Trono. 1994. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytcs. Proc. Natl. Acad. Sci. USA 91:6992-6996.
37. Wills, J. W., and R. C. Craven. 1991. Form, function, and use of retroviral gag proteins. AIDS 5:639-654. (Editorial.)
38. Yu, G., F. S. Shen, S. Sturch, A. Aquino, R. I. Glazer, and R. L. Felsted. 1995. Regulation of HIV-1 gag protein subcellular targeting by protein kinasc C. J. Biol. Chem. 270:4792-4796.
39. Yu, X., Q. C. Yu, T. H. Lee, and M. Essex. 1992. The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle. J. Virol. 66:5667-5670.
40. Yu, X., X. Yuan, Z. Matsuda, T. H. Lee, and M. Essex. 1992. The matrix protein of human immunodeficiency virus type 1 is required for incorpora-1 tion of viral envelope protein into mature virions. J. Virol. 66:4966-4971.
41. Yuan, X., X. Yu, T. H. Lee, and M. Essex. 1993. Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J. Virol. 67:6387-6394.
42. Zhou, W., L. J. Parent, J. W. Wills, und M. D. Resh. 1994. Identification of a membrane-binding domain within the amino-tcrminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids, J. Virol. 68:2556-2569.
43. Zhou, W., and M. D. Resh. 1996. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J. Virol. 70:8540-8548.